How Genomics and Bioinformatics are Changing the Practice and Business of Medicine

With billions of dollars in government funding, the human genome was sequenced a decade ago. The cost of sequencing has dramatically fallen and bioinformatic computational capability is decreasing geometrically. Join clinicians, business people, genomicists and bioinformaticians to discuss these issues: Is personalized medicine now a reality? Has drug discovery been transformed? Do old business models still apply? Or have we only succeeded in increasing the disparity of available health care? Panelists include: Sandeep Dave, MD, MS, Asst Professor, DUMC; Mike Dombeck, MPP, MBA, Director, R&D Strategy and Portfolio Grp, GSK; Harold Garner, MSc, PhD, Director, Medical Informatics and Systems Division, Virginia Bioinformatics Institute, VA Tech; Hunt Willard, PhD, Director, Duke Institute for Genome Sciences & Policy; Buz Waitzkin, JD, Fuqua Adjunct Faculty